Advances in the relationship between coronavirus infection and cardiovascular diseases

Zhao, Mengmeng; Wang, Menglong; Zhang, Jishou; Ye, Jing; Xu, Yao; Wang, Zhen; Ye, Di; Liu, Jianfang; Wan, Jun

doi:10.1016/j.biopha.2020.110230

Cited by 70 publications

(94 citation statements)

References 214 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Chronic kidney disease (CKD) may be associated with a more severe form of COVID-19. 1 , 2 , 3 , 4 , 5 Dietary interventions improve health outcomes, quality of life, and health behaviors for many chronic diseases, including CKD. Self-management through an adequate diet provides beneficial results in reducing symptoms and disease progression in CKD.…”

mentioning

confidence: 99%

Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease

Mafra

Cardozo

Moraes

et al. 2021

Journal of Renal Nutrition

View full text Add to dashboard Cite

Considering the Covid-19 pandemic and that patients with CKD are included in a high-risk group, a quick nutrition guide for patients with CKD in all stages was developed, and it is available in Portuguese at https://bit.ly/2zfSjl0 , in English at https://bit.ly/covid19ckd , in Spanish at https://bit.ly/guia enfermedad renal and in French at https://bit.ly/covid19maladierenale .

show abstract

mentioning

confidence: 99%

Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease

Mafra

Cardozo

Moraes

et al. 2021

Journal of Renal Nutrition

View full text Add to dashboard Cite

show abstract

“…Cardiovascular complications mostly occur in admitted severe or fatal cases of COVID-19, that have already developed ARDS. The risk of heart injury was higher in severe cases, approximately 22.2–31%, than in mild cases, approximately 2–4% ( Zhao et al, 2020 ). Myocardial injury and acute coronary syndrome were seen as cardiovascular complications in patients with severe or fatal respiratory infection caused by SARS-CoV-2 and were the signs of poor prognosis ( Driggin et al, 2020 ).…”

Section: Covid-19 and The Cardiovascular Systemmentioning

confidence: 99%

Pathophysiology of Cardiovascular Complications in COVID-19

Petrović

Radenković

et al. 2020

Front. Physiol.

View full text Add to dashboard Cite

Numerous recent studies have shown that patients with underlying cardiovascular disease (CVD) are at increased risk of more severe clinical course as well as mortality of COVID-19. Also, the available data suggests that COVID-19 is related to numerous de novo cardiovascular complications especially in the older population and those with pre-existing chronic cardiometabolic conditions. SARS-CoV-2 virus can cause acute cardiovascular injury, as well as increase the risk of chronic cardiovascular damage. As CVD seem to be the major comorbidity in critically unwell patients with COVID-19 and patients often die of cardiovascular complications, we review the literature and discuss the possible pathophysiology and molecular pathways driving these disease processes: cytokine release syndrome, RAAS system dysregulation, plaque destabilization and coagulation disorders with the aim to identify novel treatment targets. In addition, we review the pediatric population, the major cause of the cardiovascular complications is pediatric inflammatory multisystem syndrome that is believed to be associated with COVID-19 infection. Due to the increasingly recognized CVD damage in COVID-19, there is a need to establish clear clinical and follow-up protocols and to identify and treat possible comorbidities that may be risk factors for the development of cardiovascular complications.

show abstract

“…Differences in host susceptibility to viruses and immune systems can also be considered as important prognostic factors. Recently, some studies show that cardiovascular diseases such as hypertension increased the incidence and severity of coronavirus infection (80). Also, myocardial injury caused by coronavirus infection contributed to poor prognosis (81).…”

Section: Prognosismentioning

confidence: 99%

Treatment and prognosis of COVID‑19: Current scenario and prospects (Review)

2020

Exp Ther Med

View full text Add to dashboard Cite

SARS-CoV-2 is the seventh member of the family of coronaviruses that can cause infections in humans, termed as COVID-19, which is now a global pandemic. Because it is a novel virus, considerable efforts and extensive studies are needed to fully understand its characteristics. Its symptoms and severity range from mild to critical, depending on several factors, such as host susceptibility to the virus and their immune system, with the most common symptoms being fever, fatigue, sore throat and runny nose. There is no clear treatment available yet, though several options are being explored, with research for vaccines being at the forefront. Traditional Chinese Medicine may also be used as a treatment option. Since this virus is similar to the SARS-CoV and MERS viruses, considerable insight can be gained from previous studies. Although many patients recover completely, there are several factors that lead to poor prognosis. This review summarizes the research carried out so far in terms of treatment options and prognosis factors associated with COVID-19. Contents 1. Introduction 2. Clinical features of COVID-19 3. Current COVID-19 treatment options 4. Prognosis 5. Conclusion

show abstract

Advances in the relationship between coronavirus infection and cardiovascular diseases

Cited by 70 publications

References 214 publications

Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease

Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease

Pathophysiology of Cardiovascular Complications in COVID-19

Treatment and prognosis of COVID‑19: Current scenario and prospects (Review)

Contact Info

Product

Resources

About